Status:
TERMINATED
Keppra for Cervical Dystonia
Lead Sponsor:
University of South Florida
Conditions:
Cervical Dystonia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate if there is an improved response in CD symptoms when Keppra is used as adjunctive therapy to Botox.
Detailed Description
Up to 40 patients with cervical dystonia and receiving intermittent Botox injections will be enrolled in the study. Patients will be evaluated at baseline 12-16 weeks following their prior set of Boto...
Eligibility Criteria
Inclusion
- Patients will have received their last Botox injections 12-16 weeks ago
- Any oral medications for cervical dystonia will be stable for 4 weeks and will continue throughout the study
Exclusion
- Less than 21 years old
- Received Botox more than 16 weeks ago
- Not on a stable dose of oral medications for cervical dystonia
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT00760318
Start Date
November 1 2005
End Date
October 1 2007
Last Update
November 23 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.